WG
ABEO icon

Winton Group’s Abeona Therapeutics ABEO Stock Holding History

Winton Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Buy
+41,400
New +$227K 0.01% 941
2020
Q1 		– Sell
-8,209
Closed -$671K – 1376
2019
Q4 		$671K Buy
+8,209
New +$579K 0.01% 1160

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Winton Group's ABEO Position: Q2 2026 in Review

Winton Group opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 41,400 shares worth $256K. The stake represents 0.01% of the portfolio and ranks #941 among its holdings. This is a return to the name: Winton Group previously reported a position in ABEO as recently as Q4 2019.

Winton Group first reported a position in ABEO in Q4 2019 and has held it in 2 quarters since. The position peaked at $671K in Q4 2019. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Winton Group held 41,400 shares of Abeona Therapeutics worth $256K as of Q2 2026.
  • Abeona Therapeutics was a new Winton Group position in Q2 2026.
  • Abeona Therapeutics made up 0.01% of Winton Group's portfolio in Q2 2026, its #941 holding.
  • Winton Group first reported a position in Abeona Therapeutics in Q4 2019 and has held it in 2 quarters since.
  • Winton Group's Abeona Therapeutics position peaked at $671K in Q4 2019.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.